Oöcytes for research: Inspecting the commercialization continuum

New Genetics and Society

Volumn 31, Issue 2, 2012, Pages 135-157

  Braun, Kathrin ^a   Schultz, Susanne ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Gen ethisches Netzwerk eV   (Germany)

Author keywords

commercialization; o cyte procurement; stem cell research

Indexed keywords

ARTICLE; CELL CLONING; CELL TRANSFER; CELL TRANSPLANTATION; CLINICAL PRACTICE; COMMERCIAL PHENOMENA; DONOR; EUROPE; FERTILIZATION; FERTILIZATION IN VITRO; GOVERNMENT; HEALTH CARE POLICY; HUMAN; HUMAN RIGHTS; KNOWLEDGE MANAGEMENT; MEDICAL DECISION MAKING; MEDICAL ETHICS; MEDICAL RESEARCH; NONHUMAN; OOCYTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SOMATIC CELL; STEM CELL; UNITED STATES;

EID: 84862214755     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2011.603953     Document Type: Article

References (35)

1. Baart, E.B., et al., 2007. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Human Reproduction, 22 (4), 980-988.
2. Baylis, F. and Mcleod, C., 2007. The stem cell debate continues: the buying and selling of eggs for research. Journal of Medical Ethics, 33, 726-731.
3. Beeson, D. and Lippman, A., 2006. Egg harvesting for stem cell research: medical risks and ethical problems. Reproductive BioMedicine Online, 13 (4), 573-579 [online]. Available from http://www.sciencedirect.com/science/article/ pii/S1472648310606475 [Accessed 25 July 2011].
4. Delvigne, A. and Rozenberg, S., 2002. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update, 8 (6), 559-577.
5. Dickensen, D. and Alkorta Idiakez, I., 2008. Ova donation for stem cell research: an international perspective. International Journal of Feminist Approaches to Bioethics, 1 (2), 1-17.
6. Franklin, S., 2006. Embryonic economies: the double reproductive value of stem cells. BioSocieties, 1 (1), 71-90.
7. Gottweis, H. and Triendl, R., 2006. South Korean policy failure and the Hwang debacle. Nature Biotechnology, 24 (2), 141-143.
8. Guidice, L., Santa, E., and Pool, R., ed., 2007. L. Guidice, ed. Assessing the medical risks of human oöcyte donation for stem cell research: workshop report. Washington, DC: National Academies Press.
9. Gupta, J.A., 2006. Towards transnational feminisms: some reflections and concerns in relation to the globalization of reproductive technologies. European Journal of Women's Studies, 13 (1), 23-38. ISCO 2010. International Stem Cell Corporation progress towards Establishment of the Industry's First Universal Stem Cell Bank, UniStemCellTM. Press Release 25 January 2010 [online]. Available from http://www.internationalstemcell.com/news2010htm# [Accessed 25 July 2011].
10. Heijnen, E., et al., 2007.Amild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. The Lancet, 369 (9563), 743-749.
11. Hoyer, K., 2007. Person, patent and property: a critique of the commodification hypothesis. BioSocieties, 2, 327-348.
12. Hugues, J.-N., 2002. Ovarian stimulation for assisted reproductive technologies. In: E. Vayena, P.J. Rowe and D.P. Griffin, eds. Current practices and controversies in assisted reproduction. Report of a meeting on Medical, Ethical and Social Aspects of Assisted Reproduction, held at WHO headquarters 17-21 September 2001 Geneva, Switzerland. Geneva:World Health Organization, 102-125.
13. Ikemoto, L.C., 2009. Eggs as capital: human egg procurement in the fertility industry and the stem cell research enterprise. Signs, 34 (4), 763-781.
14. Jayaprakasan, K., et al., 2007. Estimating the risks of ovarian hyperstimulation syndrome (OHSS): implications for egg donation for research. Human Fertility, 10 (3), 183-187.
15. Kramer, W., Schneider, J., and Schultz, N., 2009. US oöcyte donors: a retrospective study of medical and psychological issues. Human Reproduction Advance Access, 24 (12), 3144-3149.
16. Leem, S.Y. and Park, J.H., 2008. Rethinking women and their bodies in the age of biotechnology: feminist commentaries on the Hwang affair. East Asian Science, Technology and Society: An International Journal (EASTS), 2 (1), 9-26.
17. Levin, A.D., 2010. Self-regulation, compensation, and the ethical recruitment of oöcyte donors. Hastings Center Report, 40 (2), 25-36.
18. Magnus, D. and Cho, M.K., 2005. Issues in oöcyte donation for stem cell research. Science, 308, 1747-1748.
19. Mertes, H. and Pennings, G., 2007. Oöcyte donation for stem cell research. Human Reproduction, 22 (3), 629-634.
20. Nargund, G., et al., 2007. Low dose HGC is useful in preventing OHSS in high risk women without adversely affecting the outcome of IVF cycles. Reproductive BioMedicine Online, 14 (6), 682-685.
21. Norsigian, J., 2005. Egg donation for IVF and stem cell research: Time to weigh the risks to women's health. Different Takes, 33 [online]. Available from http://www.global-sisterhood-network.org/content/view/227/59 [Accessed 25 July 2011].
22. O'Riordan, K. and Haran, J., 2009. From reproduction to research. Sourcing eggs, IVF, and cloning in the UK. Feminist Theory, 10 (2), 191-210.
23. Orobitg, G. and Salazar, C., 2005. The gift of motherhood: egg donation in a Barcelona infertility clinic. Ethnos, 70 (1), 31-52.
24. Pearson, H., 2006. Health effects of egg donation may take decades to emerge. Nature, 442, 607-608.
25. Pennings, G., 2006. Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers. Reproductive BioMedicine Online, 13 (1), 8-10.
26. Roberts, C. and Throsby, K., 2008. Paid to share: IVF patients, eggs and stem cell research. Social Science & Medicine, 66 (1), 159-169.
27. Schneider, I., 2006. Oöcyte donation for reproduction and research cloning - the perils of commodification and the need for European and international regulation. Law and the Human Genome, 25, 205-241.
28. Schultz, S., 2010. Women's eggs for research: without payment? Center for Genetics and Society, 14 October [online]. Available from: http://www. geneticsandsociety.org/article.php?id=5413 [Accessed 25 July 2011].
29. Sexton, S., 2006. Ethics of economics? Health or wealth? Beyond ova in the lab. Paper presented at the Conference on Envisioning the Human Rights of Women in the Age of Biotechnology and Science, 21 September, Seoul, South Korea.
30. Spar, D., 2007. The egg trade - making sense of the market for human oöcytes. New England Journal of Medicine, 356, 1289-1291.
31. Steinbock, B., 2009. Paying egg donors for research: in defense of New York's landmark decision. Bioethics Forum, 1 July [online]. Available from: http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=3638 [Accessed 25 July 2011].
32. Thompson, C., 2007. Why we should, in fact, pay for egg donation. Regenerative Medicine, 2 (2), 203-209.
33. Waldby, C., 2008. Oöcyte markets: women's reproductive work in embryonic stem cell research. New Genetics and Society, 27 (1), 19-31.
34. Waldby, C. and Cooper, M., 2008. The biopolitics of reproduction. Australian Feminist Studies, 23 (55), 57-73.
35. Waldby, C. and Cooper, M., 2010. From reproductive work to regenerative labour: the female body and the stem cell industries. Feminist Theory, 11 (3), 3-22.